Table 1.
Demographic and Clinical Characteristics of Study Participants
| Characteristics | N (%) |
|---|---|
| Gender | |
| Male | 10 (56) |
| Female | 8 (44) |
| Stage | |
| II | 1 (06) |
| III | 17 (94) |
| Chemotherapy | |
| 5-FU 225 mg/m2 over 24 Hours | 11 (61) |
| Oral Capecitabine 825mg/m2 twice/day, 5 days per week | 7 (39) |
| Racial categories | |
| Non-Hispanic White | 8 (44) |
| Hispanic White | 7 (39) |
| African American | 2 (11) |
| Asian | 1 (06) |
| Marital status | |
| Married/partnered | 12 (67) |
| Single/divorced | 4 (22) |
| Widow | 2 (11) |
| Occupation | |
| Working | 13 (72) |
| Retired | 2 (11) |
| Handicap | 2 (11) |
| Unemployed | 1 (06) |
| Mean | |
| Age | 59 ± 11.34 |
| Number of Radiotherapy days | 28 ± 4.4 |